Correction to “C/EBPβ Enhances Efficacy of Sorafenib in Hepatoblastoma”

Read full text
Cited by: 0

Abstract

Pang, C., Miao, H., Zuo, Y., Guo, N., Sun, D., & Li, B. (2021). C/EBPβ enhances efficacy of sorafenib in hepatoblastoma. Cell Biol Int, 45, 1897–1905, https://doi.org/10.1002/cbin.11624 In the originally published article, the Funding Information section was incomplete due to the inadvertent omission of a grant. The complete and corrected Funding Information section should read as follows: Funding information The Natural Science Foundation of Hebei province, Grant/Award Number: H2021406043; 2021 Research Start-up Fund for High-level Talents of Chengde Medical College, Grant/Award Number: 202109; Science and Technology Research and Development Program of Chengde, Grant/Award Number: 201904A097; the school private research management of Chengde Medical University, Grant/Award Numbers: 201814, 202004. We apologize for this error.

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Liver physiology and pathology Colorectal Cancer Treatments and Studies

Publication details

Journal / source
Cell Biology International
Volume
50
Issue
1
Publication date
1 January 2026
Language
EN